Joseph Gilliam

Joseph Gilliam has served as President and Chief Operating Officer of Glaukos Corporation since April 2022. Previously, he served as Glaukos’s Chief Financial Officer and Senior Vice President, Corporate Development from May 2017 to April 2022. From 2013 to May 2017, he was a Managing Director in the Healthcare Investment Banking group at JPMorgan Chase & Co. From 2000 to 2013, Mr. Gilliam held positions of increasing responsibility at JPMorgan Chase & Co. and its predecessor organizations The Beacon Group and Chase Manhattan, with experience spanning mergers and acquisitions, primary and secondary public equity offerings, bank lending, bond offerings and other transactions. He started his career at PricewaterhouseCoopers LLP. Mr. Gilliam currently sits on the board of directors of Caris Life Sciences, where he also serves on the audit and compensation committees. Mr. Gilliam has a B.S. in accounting from the Kelley School of Business at Indiana University.